Atlas Trials

Safety Study to Evaluate FluMist in Immunocompromised Children

Clinical trial NCT00112112 · COMPLETED

Trial details

NCT number
NCT00112112
Sponsor
MedImmune LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2005-08-01
Primary completion
2008-03-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.